Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Z
Zaffaroni, Nadia
Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 01
)
ANTITUMOR ACTIVITY OF CYTOTOXIC AND TARGETED AGENTS IN A PATIENT-DERIVED XENOGRAFT (PDX) OF DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) HIGHLIGHTS THE IRINOTECAN-TRABECTEDIN COMBINATION
Nadia Zaffaroni
Favorite
(
P 170
)
ANTITUMOR ACTIVITY OF TAZEMETOSTAT AND DOXORUBICIN COMBINATION ON PATIENT-DERIVED PRECLINICAL MODELS OF EPITHELIOID SARCOMA
Nadia Zaffaroni
Favorite
(
P 188
)
PRELIMINARY ASSESSMENT OF CIRCULATING INFLAMMATORY CYTOKINES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) PATIENTS AND IN AN EHE PATIENT-DERIVED XENOGRAFT BEFORE AND AFTER DOXORUBICIN AND SIROLIMUS
Nadia Zaffaroni
Favorite
Zagonel, Vittorina
Veneto Institute of Oncology IOV – IRCCS
(
P 06
)
GONADOTOXICITY RISK EVALUATION AND REPRODUCTIVE OUTCOMES IN YOUNG ADULTS WITH SOFT TISSUE AND BONE SARCOMA TREATED WITH CHEMOTHERAPY AND/OR RADIATION THERAPY: A SINGLE CENTER RETROSPECTIVE STUDY
Vittorina Zagonel
Favorite
Zahler, Stacey
Cleveland Clinic
(
P 311
)
VIRTUAL VISITS FOR SARCOMAS AND OTHER RARE CANCERS INCLUDING DESMOIDS: THE EVOLUTION OF INFORMATION AND EDUCATIONAL OPPORTUNITIES TO IMPOVE HEALTH: 2017-2022
Stacey Zahler
Favorite
Zaidi, Shane
The Royal Marsden Hospital
(
P 085
)
RADIATION ASSOCIATED ANGIOSARCOMAS OF THE BREAST: MULTIFOCALITY WARRANTS AGGRESSIVE ONCOLOGICAL STRATEGY
Shane Zaidi
Favorite
(
P 152
)
FINAL RESULTS OF GEMMK: A PHASE I TRIAL OF GEMCITABINE AND PEMBROLIZUMAB IN PATIENTS WITH LEIOMYOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Shane Zaidi
Favorite
Zając, Agnieszka
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
(
P 245
)
MUTATIONAL STATUS OF CHONDROSARCOMA BASED ON TARGETED NEXT-GENERATION SEQUENCING ANALYSIS
Agnieszka Zając
Favorite
Zaniletti, Isabella
Department of Qualitative Health Sciences, Section of Biostatistics, Mayo Clinic
(
P 202
)
LONG-TERM EXPERIENCE WITH INTRAOPERATIVE ELECTRON RADIATION THERAPY BOOST IN EXTREMITY SARCOMA
Isabella Zaniletti
Favorite
Zarate, Stephanie
Miami Cancer Institute
(
P 077
)
FREEZING IN FLORIDA: ARE WE READY FOR DIVERSITY?
Stephanie Zarate
Favorite
Zavras, Athan
Allegheny General Hospital
(
P 273
)
3D-PRINTED PATIENT-SPECIFIC CUTTING GUIDES VERSUS FREEHAND RESECTION FOR INTERNAL HEMIPELVECTOMY: CLINICAL AND ONCOLOGIC OUTCOMES
Athan Zavras
Favorite
(
P 277
)
BEARING SELECTION IN PROXIMAL FEMORAL REPLACEMENT: A COMPARISON OF CLINICAL OUTCOMES
Athan Zavras
Favorite
(
P 287
)
INTERNAL HEMIPELVECTOMY: A SINGLE INSTITUTION'S LEARNING CURVE AND LONGITUDINAL EXPERIENCE
Athan Zavras
Favorite
(
P 295
)
PERIACETABULAR INTERNAL HEMIPELVECTOMY WITH AND WITHOUT SACRAL RESECTION: AN INSTITUTIONAL EXPERIENCE AND SYSTEMATIC REVIEW
Athan Zavras
Favorite
(
P 300
)
RECONSTRUCTION FOLLOWING SACROILIAC TUMOR RESECTION: A SYSTEMATIC REVIEW
Athan Zavras
Favorite
Zdanowicz, Anya
Children's Hospital Los Angeles
(
P 045
)
DETECTION OF CELL-FREE TUMOR DNA IN PATIENTS WITH NEWLY DIAGNOSED PEDIATRIC BONE AND SOFT TISSUE SARCOMAS
Anya Zdanowicz
Favorite
Zeitlinger, Lauren
University of California, Davis
(
P 095
)
A COLLABORATIVE MULTIDISCIPLINARY APPROACH MAY LEAD TO ENHANCED CLINICAL OUTCOMES AND QUALITY OF CARE FOR PATIENTS WITH DIFFUSE TGCT
Lauren Zeitlinger
Favorite
Zemp, Franz
University of Calgary
(
P 128
)
INVESTIGATING THE ROLE OF MACROPHAGES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Franz Zemp
Favorite
Zer, Alona
(
P 257
)
SELECTIVE INTRA-ARTERIAL DOXORUBICIN-ELUTING EMBOLIZATION FOR DESMOID FIBROMATOSIS: A COMBINED PROSPECTIVE AND RETROSPECTIVE STUDY
Alona Zer
Favorite
Zhang, Betty
Chris O'Brien Lifehouse
(
P 149
)
CHARACTERISTICS OF PATIENTS WITH BONE AND SOFT TISSUE SARCOMAS REFERRED TO A DEDICATED EARLY PHASE CLINICAL TRIAL CLINIC
Betty Zhang
Favorite
(
P 258
)
TO TREAT OR NOT TO TREAT: AN AUDIT OF INITIAL MANAGEMENT OF PATIENTS WITH DESMOID TUMOURS AT A SPECIALISED CENTRE
Betty Zhang
Favorite
Zhang, Enlong
Department of Radiology, Peking University International Hospital
(
P 222
)
SURGICAL RESECTION OF ABDOMINOPELVIC AGGRESSIVE ANGIOMYXOMA: A RETROSPECTIVE REVIEW OF 12 CONSECUTIVE CASES
Enlong Zhang
Favorite
Zhang, Hua
The Clinical Epidemiology Research Center, Peking University Third Hospital
(
P 211
)
ANESTHESIA MANAGEMENTS AND POSTOPERATIVE MORTALITIES IN RETROPERITONEAL SARCOMA PATIENTS EXPERIENCING MASSIVE BLOOD TRANSFUSION DURING SURGERIES
Hua Zhang
Favorite
Zhang, Joey Yingjun
The Chinese University of Hong Kong
(
P 186
)
PRECLINICAL STUDY OF DOXORUBICIN IN COMBINATION WITH PANOBINOSTAT IN XENOGRAFT MICE MODELS OF SOFT TISSUE SARCOMAS
Joey Yingjun Zhang
Favorite
Zhang, Lingxin
Mount Sinai Hospital/University of Toronto
(
P 304
)
SURGICAL STAGING OF OSTEOSARCOMA: WHAT IS THE OPTIMAL METHOD FOR PREDICTING LOCAL RECURRENCE?
Lingxin Zhang
Favorite
Zhang, Xin
Shanghai OrigiMed Co., Ltd
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Xin Zhang
Favorite
Zhang, Xinhua
Gastrointestinal Surgery Center, The First Affiliated Hospital of Sun Yat-sen University
(
P 101
)
CYTOREDUCTIVE SURGERY FOR METASTATIC GASTROINTESTINAL STROMAL TUMORS TREATED WITH RIPRETINIB: A SINGLE-CENTER ANALYSIS.
Xinhua Zhang
Favorite
(
P 111
)
PLASMA CONCENTRATION MONITORING AND PERSONALIZED DESENSITIZATION THERAPY IN PATIENTS OF GASTROINTESTINAL STROMAL TUMORS WITH IMATINIB-ASSOCIATED SKIN RASH
Xinhua Zhang
Favorite
Zhang, Yawen
Shanghai Sixth People's Hospital
(
P 136
)
PRELIMINARY EFFICACY AND SAFETY OF FAMITINIB PLUS SHR-1701 IN ADVANCED SARCOMA: A SINGLE-CENTER, PHASE 2 TRIAL
Yawen Zhang
Favorite
Zhang, Yefan
Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical S
(
P 097
)
COMBINATION THERAPY OF TYROSINE KINASE INHIBITORS WITH RIPRETINIB AS THERAPEUTIC EXPLORATION FOR REFRACTORY GASTROINTESTINAL STROMAL TUMORS AFTER PROGRESSION FROM STANDARD THERAPY: A CASE REPORT
Yefan Zhang
Favorite
Zhao, Changhong
Jiangsu Hengrui Pharmaceuticals
(
P 136
)
PRELIMINARY EFFICACY AND SAFETY OF FAMITINIB PLUS SHR-1701 IN ADVANCED SARCOMA: A SINGLE-CENTER, PHASE 2 TRIAL
Changhong Zhao
Favorite
Zhao, Sophia
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT
(
P 178
)
HIGH FREQUENCY OF NAPRT-SILENCING IN NEUROBLASTOMA AND RHABDOMYSARCOMA CONFERS SENSITIVITY TO TARGETING OF NAD+ METABOLISM USING NAMPT INHIBITORS
Sophia Zhao
Favorite
Zheng, Cheng
Zentalis
(
P 144
)
A PHASE 1/2 DOSE ESCALATION/EXPANSION STUDY OF ZN-C3 PLUS GEMCITABINE IN RELAPSED/REFRACTORY OSTEOSARCOMA
Cheng Zheng
Favorite
Zheng, Qiongdan
University of Miami
(
P 098
)
COMBINATION THERAPY WITH IMATINIB AND PAC-1 INDUCES TREATMENT SYNERGISM IN GASTROINTESTINAL STROMAL TUMORS
Qiongdan Zheng
Favorite
Zhou, Maggie
Department of Medicine, Division of Oncology, Stanford University
(
P 047
)
FEASIBILITY OF A PERSONALIZED AND TUMOR-INFORMED CT-DNA ASSAY IN PATIENTS WITH LEIOMYOSARCOMA
Maggie Zhou
Favorite
Zhou, Qianhe
Foghorn Therapeutics
(
P 187
)
PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA
Qianhe Zhou
Favorite
Zhou, Yan
Shanghai Sixth People's Hospital
(
P 136
)
PRELIMINARY EFFICACY AND SAFETY OF FAMITINIB PLUS SHR-1701 IN ADVANCED SARCOMA: A SINGLE-CENTER, PHASE 2 TRIAL
Yan Zhou
Favorite
Zhou, Yong
Department of Orthopedics, West China Hospital, Sichuan University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Yong Zhou
Favorite
Ziegler, David S.
Sydney Children’s Hospital, Randwick, NSW, Australia and School of Women’s and Children’s Health, University of New South Wales Sydney
(
P 107
)
LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
David S. Ziegler
Favorite
Zlobec, Inti
Translational Research Unit, Institute of Pathology, University of Bern
(
P 182
)
NOVEL TISSUE MICROARRAY (TMA) PLATFORM AS A TOOL FOR COLLABORATIVE SOFT TISSUE SARCOMA (STS) RESEARCH
Inti Zlobec
Favorite
Zöllner, Stefan
University Hospital Essen, Pediatrics III, Essen, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Stefan Zöllner
Favorite
Zouaoui, Sonia
CHU MONTPELLIER
(
P 080
)
INTRACRANIAL SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA MANAGEMENT: A FRENCH MULTICENTRE RETROSPECTIVE STUDY
Sonia Zouaoui
Favorite
Zou, Qingping
Abbisko Therapeutics
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Qingping Zou
Favorite
Zou, Trudy
University of Pittsburgh Medical Center
(
P 087
)
RATING THE EFFICACY OF DIAGNOSTIC IMAGING STUDIES PERFORMED FOR THE WORK-UP OF MUSCULOSKELETAL MASSES
Trudy Zou
Favorite
Zou, Trudy
University of Pittsburgh School of Medicine
(
P 244
)
MUTATIONAL BURDEN OF COPY NUMBER VARIANTS VS STRUCTURAL VARIANTS IN EXTRASKELETAL MYXOID CHONDROSARCOMA: A CASE STUDY
Trudy Zou
Favorite
Zuco, Valentina
Fondazione IRCCS Istituto Nazionale dei Tumori
(
P 01
)
ANTITUMOR ACTIVITY OF CYTOTOXIC AND TARGETED AGENTS IN A PATIENT-DERIVED XENOGRAFT (PDX) OF DESMOPLASTIC SMALL ROUND CELL TUMOR (DSRCT) HIGHLIGHTS THE IRINOTECAN-TRABECTEDIN COMBINATION
Valentina Zuco
Favorite
(
P 170
)
ANTITUMOR ACTIVITY OF TAZEMETOSTAT AND DOXORUBICIN COMBINATION ON PATIENT-DERIVED PRECLINICAL MODELS OF EPITHELIOID SARCOMA
Valentina Zuco
Favorite
(
P 188
)
PRELIMINARY ASSESSMENT OF CIRCULATING INFLAMMATORY CYTOKINES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) PATIENTS AND IN AN EHE PATIENT-DERIVED XENOGRAFT BEFORE AND AFTER DOXORUBICIN AND SIROLIMUS
Valentina Zuco
Favorite
Zurlo, Christian
Veneto Institute of Oncology IOV – IRCCS
(
P 06
)
GONADOTOXICITY RISK EVALUATION AND REPRODUCTIVE OUTCOMES IN YOUNG ADULTS WITH SOFT TISSUE AND BONE SARCOMA TREATED WITH CHEMOTHERAPY AND/OR RADIATION THERAPY: A SINGLE CENTER RETROSPECTIVE STUDY
Christian Zurlo
Favorite
Back to Top
